MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 78 filers reported holding MERSANA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $477,210 | -61.5% | 375,756 | -0.2% | 0.00% | – |
| Q2 2023 | $1,239,247 | -18.5% | 376,671 | +1.9% | 0.00% | – |
| Q1 2023 | $1,519,821 | -29.5% | 369,786 | +0.5% | 0.00% | – |
| Q4 2022 | $2,156,650 | -11.5% | 368,029 | +2.1% | 0.00% | -100.0% |
| Q3 2022 | $2,437,000 | +53.5% | 360,596 | +4.9% | 0.00% | – |
| Q2 2022 | $1,588,000 | +40.5% | 343,712 | +21.4% | 0.00% | – |
| Q1 2022 | $1,130,000 | -35.1% | 283,095 | +1.1% | 0.00% | – |
| Q4 2021 | $1,742,000 | -31.8% | 279,930 | +3.4% | 0.00% | – |
| Q3 2021 | $2,553,000 | -24.5% | 270,809 | +8.8% | 0.00% | -100.0% |
| Q2 2021 | $3,381,000 | -20.1% | 249,001 | -4.8% | 0.00% | 0.0% |
| Q1 2021 | $4,232,000 | -42.5% | 261,511 | -5.4% | 0.00% | -50.0% |
| Q4 2020 | $7,357,000 | +41.9% | 276,478 | -0.7% | 0.00% | +100.0% |
| Q3 2020 | $5,184,000 | -18.3% | 278,372 | +2.6% | 0.00% | -50.0% |
| Q2 2020 | $6,349,000 | +458.4% | 271,341 | +39.1% | 0.00% | – |
| Q1 2020 | $1,137,000 | +2.2% | 195,019 | +0.4% | 0.00% | – |
| Q4 2019 | $1,113,000 | +595.6% | 194,243 | +92.1% | 0.00% | – |
| Q3 2019 | $160,000 | -63.1% | 101,100 | -5.7% | 0.00% | – |
| Q2 2019 | $434,000 | +112.7% | 107,201 | +176.7% | 0.00% | – |
| Q1 2019 | $204,000 | +27.5% | 38,744 | -1.2% | 0.00% | – |
| Q4 2018 | $160,000 | -51.4% | 39,203 | +19.2% | 0.00% | – |
| Q3 2018 | $329,000 | -41.7% | 32,897 | +4.1% | 0.00% | – |
| Q2 2018 | $564,000 | +43.9% | 31,615 | +27.4% | 0.00% | – |
| Q1 2018 | $392,000 | +54.3% | 24,811 | +60.9% | 0.00% | – |
| Q4 2017 | $254,000 | +10.0% | 15,417 | +15.4% | 0.00% | – |
| Q3 2017 | $231,000 | – | 13,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |